This analysis further highlights hematopoietic stem progenitor (HSCP) programs (Gfi1b, Meis1, Gata3, Ikzf2) are active in later progenitor populations (AML IG2 and monocytic), where they should normally be down-regulated (1). This evidence concerns the gene IKZF2 and acute myeloid leukemia.